scholarly journals Synchronous endometrial and ovarian cancer in Lynch syndrome with a MSH2 germline mutation: A case report

Author(s):  
Takashi Takeda ◽  
Kouji Banno ◽  
Megumi Yanokura ◽  
Mayuka Anko ◽  
Arata Kobayashi ◽  
...  
2019 ◽  
Vol 7 (6) ◽  
Author(s):  
Xiaoqing Guo ◽  
Weimin Wu ◽  
Hao Gao ◽  
Xiaofeng Li ◽  
Qizhi He ◽  
...  

2018 ◽  
Vol 10 (9) ◽  
Author(s):  
Salha Bujassoum ◽  
Reem Alsulaiman ◽  
Hind Elmalik ◽  
Kulssom Junejo ◽  
Ahmed Mahfouz ◽  
...  

2016 ◽  
Vol 43 (2) ◽  
pp. 416-420 ◽  
Author(s):  
Masataka Adachi ◽  
Kouji Banno ◽  
Kenta Masuda ◽  
Megumi Yanokura ◽  
Moito Iijima ◽  
...  

2020 ◽  
Vol 18 (4) ◽  
Author(s):  
Sudha S. Murthy ◽  
Vaishnavi Kunteepuram ◽  
Krishna Mohan Mallavarapu ◽  
T. Nageswara Rao ◽  
B. Vishal Rao ◽  
...  

2020 ◽  
Vol 2 (7) ◽  
pp. 1012-1015
Author(s):  
Takuya Yokoe ◽  
Katsuhiko Yasuda ◽  
Tomoo Yoshimura ◽  
Aoi Hattori ◽  
Tomomi Mizokami ◽  
...  

2005 ◽  
Vol 23 (36) ◽  
pp. 9344-9350 ◽  
Author(s):  
Pamela T. Soliman ◽  
Russell R. Broaddus ◽  
Kathleen M. Schmeler ◽  
Molly S. Daniels ◽  
Delia Gonzalez ◽  
...  

Purpose Lynch syndrome (hereditary nonpolyposis colorectal cancer; HNPCC) is an autosomal-dominant cancer predisposition syndrome that increases risk for multiple cancers, including colon, endometrial, and ovarian cancer. Revised Bethesda Criteria recommend that patients with two HNPCC-associated cancers undergo molecular evaluation to determine whether they have a mismatch repair (MMR) defect associated with HNPCC. The purpose of our study was to determine the likelihood of MMR defects (MSH2, MSH6, MLH1) in women with synchronous endometrial and ovarian cancer. Patients and Methods Between 1989 and 2004, 102 women with synchronous endometrial and ovarian cancers were identified; 59 patients had tumor blocks available for analysis. Patients were divided into risk groups based on family history: high (met Amsterdam criteria), medium (personal history or first-degree relative with an HNPCC-associated cancer), and low (all others). Protein expression for MSH2, MSH6, and MLH1 was evaluated by immunohistochemistry. Microsatellite instability and MLH1 promoter methylation analyses were performed on a subset of cases. Results Median age was 50 years. Two patients met Amsterdam criteria for HNPCC. Five additional patients, all medium-risk, had molecular findings consistent with a germline mutation of either MSH2 or MLH1. None of the low-risk patients had molecular results consistent with a germline mutation. Conclusion Overall, 7% of women in our cohort met either clinical or molecular criteria for Lynch syndrome. All of these women had a prior history or a first-degree relative with an HNPCC-associated cancer. Limiting genetic evaluation to women with synchronous endometrial and ovarian cancer who have a family history suggestive of HNPCC may appropriately identify women with Lynch syndrome.


Sign in / Sign up

Export Citation Format

Share Document